Search Results - "Shareb, Raghda Abu"

Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer by Novoplansky, Ofra, Shnerb, Avital B., Marripati, Divyasree, Jagadeeshan, Sankar, Abu Shareb, Raghda, Conde‐López, Cristina, Zorea, Jonathan, Prasad, Manu, Ben Lulu, Talal, Yegodayev, Ksenia M., Benafsha, Chen, Li, Yushi, Kong, Dexin, Kuo, Fengshen, Morris, Luc G. T., Kurth, Ina, Hess, Jochen, Elkabets, Moshe

“…Blocking the mitogen‐activated protein kinase (MAPK) pathway with the MEK1/2 inhibitor trametinib has produced promising results in patients with head and neck…”
Get full text

Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers by Sananes, Amiram, Cohen, Itay, Allon, Irit, Ben‐David, Oshrit, Abu Shareb, Raghda, Yegodayev, Ksenia M., Stepensky, David, Elkabets, Moshe, Papo, Niv

“…Targeted therapies for prostate, breast, and ovarian cancers are based on their activity against primary tumors rather than their anti‐metastatic activity…”
Get full text

Dual inhibition of HERs and PD-1 counteract resistance in KRASG12C-mutant head and neck cancer by Novoplansky, Ofra, Jagadeeshan, Sankar, Prasad, Manu, Yegodayev, Ksenia M., Marripati, Divyasree, Shareb, Raghda Abu, Greenshpan, Yariv, Mathukkada, Sooraj, Ben-Lulu, Talal, Bhattacharya, Baisali, Porgador, Angel, Kong, Dexin, Brägelmann, Johannes, Gutkind, J. Silvio, Elkabets, Moshe

“…Abstract Background Basket clinical trials targeting the KRAS G12C -mutation in solid tumors have shown initial promise, including in orphan KRAS G12C head and…”
Get full text